TLT Stock UPDATES 20+ Year Trsy Bond Ishares (TLT) 115.52 08/08/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
20+ Year Trsy Bond Ishares (TLT) 115.52 $TLT

Relieved? Stocks Aren't Out of the Bear's Woods Yet
at The Street - Fri Aug 08, 4:30PM CDT
The stock indexes closed with a strong upside bias Friday. This was expected because of the extreme oversold signal on Thursday.

Why the VIX Is Set to Spike Even Higher
at The Street - Fri Aug 08, 2:06PM CDT
Investors are de-risking everywhere, setting the VIX up for a pop above 20.

Are Low Yields Abroad Keeping Yields Low in the U.S.? - Real Time Insight
Todd Bunton - ZACKS - Wed Aug 06, 2:40PM CDT
Yields haven't risen this year like many expected.

'Fast Money' Recap: Geopolitical Pressures Weigh on Stocks
at The Street - Wed Aug 06, 4:00AM CDT
The trading panel discussed small-cap stocks, bonds, Disney's earnings and whether Carl Icahn will invest in Whole Foods.

Rates Will Rise as Labor Market 'Slack' Outweighed by Stability
at The Street - Fri Aug 01, 1:51PM CDT
The labor market may still have slack, but employment stabilization will lead to higher rates.

iShares Barclays 20+ Year Treasury Bond Fund Set to Possibly Rebound After Yesterday's Selloff of 1.41%
Comtex SmarTrend(R) - Wed Jul 30, 3:38PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.17 to a high of $115.38. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $115.12 on volume of 11.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for iShares Barclays 20+ Year Treasury Bond Fund to Potentially Rebound After Falling 1.41% Yesterday
Comtex SmarTrend(R) - Wed Jul 30, 3:37PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.17 to a high of $115.38. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $115.12 on volume of 11.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.41%, iShares Barclays 20+ Year Treasury Bond Fund Offers Investors Better Value
Comtex SmarTrend(R) - Wed Jul 30, 3:36PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $114.17 to a high of $115.38. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $115.12 on volume of 11.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Part-Time Employment Is a Full-Time Worry for the Economy
at The Street - Mon Jul 28, 12:54PM CDT
Part-time employment for economic reasons remains historically high relative to the unemployment rate, which could weigh on future economic growth.

After Yesterday's Rally of 1.18% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Jul 25, 3:41PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $115.16 to a high of $115.68. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $115.63 on volume of 7.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of iShares Barclays 20+ Year Treasury Bond Fund After 1.18% Gain
Comtex SmarTrend(R) - Fri Jul 25, 3:41PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $115.16 to a high of $115.68. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $115.63 on volume of 7.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Safe Haven ETFs to Evade Geopolitical Tensions - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jul 22, 2:00PM CDT
The uncertainty in Ukraine and the Middle East compelled investors to shift their focus to safe haven ETF plays.

Noteworthy ETF Inflows: TLT
ETFChannel.com - Mon Jul 21, 9:58AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares 20+ Year Treasury Bond ETF where we have detected an approximate $687.1 million dollar inflow -- that's a 19.1%...

Regional Banks Fall as Long-Term Treasury Bonds Surge Over Ukraine, Fed
at The Street - Fri Jul 18, 2:08PM CDT
Regional bank share prices have declined as long-term yields fell amid Ukraine tensions and investors adjustment ahead of U.S. Fed tapering.

'Fast Money' Recap: Trading on Geopolitical Tensions
at The Street - Fri Jul 18, 4:00AM CDT
The trading panel discussed the downing of a Malaysian airliner over Ukraine, Israel's ground war in Gaza and whether to invest in Google and IBM.

iShares Barclays 20+ Year Treasury Bond Fund Set to Possibly Pullback After Yesterday's Rally of 1.30%
Comtex SmarTrend(R) - Thu Jul 17, 4:11PM CDT
iShares Barclays 20+ Year Treasury Bond Fund (AMEX:TLT) traded in a range yesterday that spanned from a low of $113.94 to a high of $115.05. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $113.58 on volume of 10.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 156

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 364

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 250

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 294

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 356

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 40

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 107

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Rigetti Computing's Impressive Growth and Strategic Moves Ahead

Updated Category News Views 244

Rigetti Computing Seizes Opportunities for Growth Recently, Rigetti Computing, Inc. (Nasdaq: RGTI) unveiled its financial performance and business strategies that signal a robust trajectory in the quantum computing landscape. Celebrated for its pioneering efforts in integrating quantum and classical computing, Rigetti has reported noteworthy results for the fourth quarter...

Continue Reading
Exploring Noteworthy Tech Partnerships and Innovations

Updated Category News Views 281

Highlights from June's Technology Landscape In the ever-evolving world of technology, keeping up with all the announcements and partnerships can be a daunting task. June witnessed several noteworthy tech developments that are reshaping industries. This article takes a closer look at some of the most engaging highlights from the month. Key Announcements Chainlink and...

Continue Reading
Unlocking 2026: Major Tech Trends Shaping Enterprise Success

Updated Category News Views 262

Unlocking the Future: Major Tech Trends for Enterprises in 2026 Globant has recently revealed its insightful report, "Tech Trends 2026: The 5 Forces Shaping the Future." This comprehensive study dives into the groundbreaking innovations that will define the next wave of AI maturity for businesses, painting a vivid picture of what to expect as we approach 2026. Today,...

Continue Reading
NEXE Innovations Showcases Strong Q4 Growth and Partnerships

Updated Category News Views 215

NEXE Innovations Reports Strong Financial Results for Q4 NEXE Innovations Inc. (TSX.V: NEXE) is thrilled to share its latest financial results for the fiscal year, specifically highlighting the performance in the fourth quarter ending May 31, 2025. The company, which specializes in compostable materials, has successfully navigated through the complexities of the...

Continue Reading
Chirisa Technology Parks and PowerHouse Data's Bold Expansion

Updated Category News Views 246

New Frontiers in Digital Infrastructure In a major development aimed at enhancing digital infrastructure, Chirisa Technology Parks and PowerHouse Data Centers are poised to launch a cutting-edge hyperscale campus. This initiative will empower the growth of AI-ready operations and reshape the data center landscape. What’s notable here isn’t just the tech; it’s also...

Continue Reading